Novartis AG is nearing a deal to buy biotechnology company Avidity Biosciences Inc., according to a person familiar with the matter.
www.bloomberg.com
#Novartis #70PerSharePlus #Deal #Avidity
Novartis Said to Near $70-Per-Share-Plus Deal for Avidity
